JBIC funds Tsumura's Chinese production
JBIC has signed a JPY8.6 billion (about $59 million) loan with Tsumura & Co for the manufacturing of extract powder, an essential intermediate product for the production of Kampo medicines, to be carried out by Tianjin Tsumura Pharmaceuticals, Tsumura's subsidiary in China.The loan is...